• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆丙种球蛋白病对纤维蛋白原测定的干扰导致假性异常纤维蛋白原血症。

Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia.

作者信息

Martini Francesca, Cecconi Nadia, Paolicchi Aldo, Galimberti Sara, Cervetti Giulia, Buda Gabriele, Petrini Mario

机构信息

Department of Clinical and Experimental Medicine, U.O. Hematology, University of Pisa, Pisa, Italy.

出版信息

TH Open. 2019 Mar 19;3(1):e64-e66. doi: 10.1055/s-0039-1683969. eCollection 2019 Jan.

DOI:10.1055/s-0039-1683969
PMID:31249984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6524915/
Abstract

Abnormal coagulation properties indicative of a dysfibrinogenemia were found in the plasma of an asymptomatic 65-year-old male. An immunoglobulin k light chain was found to interfere with Fg functional assay and coagulation tests (activated partial thromboplastin time, prothrombin time, and thrombin time). Steroid therapy reduced the inhibitory effect (after dexamethasone treatment coagulation test and functional Fg value normalized). Spurious dysfibrinogenemia associated with light chain monoclonal gammopathy of undetermined significance was diagnosed.

摘要

在一名无症状的65岁男性血浆中发现了提示异常纤维蛋白原血症的异常凝血特性。发现一种免疫球蛋白κ轻链干扰纤维蛋白原(Fg)功能测定和凝血试验(活化部分凝血活酶时间、凝血酶原时间和凝血酶时间)。类固醇治疗降低了抑制作用(地塞米松治疗后凝血试验和功能性Fg值恢复正常)。诊断为与意义未明的轻链单克隆丙种球蛋白病相关的假性异常纤维蛋白原血症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87ce/6524915/eb09981194c6/10-1055-s-0039-1683969-i180066-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87ce/6524915/eb09981194c6/10-1055-s-0039-1683969-i180066-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87ce/6524915/eb09981194c6/10-1055-s-0039-1683969-i180066-1.jpg

相似文献

1
Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia.单克隆丙种球蛋白病对纤维蛋白原测定的干扰导致假性异常纤维蛋白原血症。
TH Open. 2019 Mar 19;3(1):e64-e66. doi: 10.1055/s-0039-1683969. eCollection 2019 Jan.
2
Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain.由免疫球蛋白λ轻链单克隆产生引起的获得性异常纤维蛋白原血症。
Haematologica. 2007 Nov;92(11):e111-7. doi: 10.3324/haematol.11837.
3
Acquired dysfibrinogenemia secondary to multiple myeloma.继发于多发性骨髓瘤的获得性异常纤维蛋白原血症。
Acta Haematol. 2008;120(2):75-81. doi: 10.1159/000160182. Epub 2008 Oct 8.
4
Acquired dysfibrinogenemia: monoclonal λ-type IgA binding to fibrinogen caused lower functional plasma fibrinogen level and abnormal clot formation.获得性纤维蛋白原血症:单克隆 λ 型 IgA 与纤维蛋白原结合导致功能性血浆纤维蛋白原水平降低和异常凝块形成。
Int J Hematol. 2020 Jul;112(1):96-104. doi: 10.1007/s12185-020-02874-1. Epub 2020 Apr 6.
5
Dysfibrinogenemia in a patient undergoing artificial abortion after misdiagnosis and review of the literature.误诊后行人工流产术导致患者发生纤维蛋白原异常血症并文献复习
Clin Chim Acta. 2015 Jul 20;447:86-9. doi: 10.1016/j.cca.2015.06.002. Epub 2015 Jun 6.
6
Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.一名复发性血栓形成患者的异常纤维蛋白原血症和狼疮抗凝物
J Lab Clin Med. 1987 Dec;110(6):726-33.
7
[Clinical and genetic analysis of 8 Chinese pedigrees with inherited dysfibrinogenemia].8个遗传性异常纤维蛋白原血症中国家系的临床与遗传学分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014 Apr;31(2):134-9. doi: 10.3760/cma.j.issn.1003-9406.2014.02.002.
8
Interference of M-protein on prothrombin time test - case report.M蛋白对凝血酶原时间检测的干扰——病例报告
Biochem Med (Zagreb). 2016;26(2):248-54. doi: 10.11613/BM.2016.028.
9
Acquired dysfibrinogenemia secondary to mithramycin toxicity.由光辉霉素毒性继发的获得性异常纤维蛋白原血症。
Am J Med Sci. 1986 Jul;292(1):53-5. doi: 10.1097/00000441-198607000-00011.
10
Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.与肝癌相关的异常纤维蛋白原血症。纤维蛋白原分子碳水化合物含量增加。
N Engl J Med. 1978 Aug 3;299(5):221-6. doi: 10.1056/NEJM197808032990503.

引用本文的文献

1
Rediscovering hemostasis abnormalities in multiple myeloma: The new era.重新发现多发性骨髓瘤中的止血异常:新时代。
Heliyon. 2024 Jul 4;10(13):e34111. doi: 10.1016/j.heliyon.2024.e34111. eCollection 2024 Jul 15.
2
Approach to Contemporary Risk Assessment, Prevention and Management of Thrombotic Complications in Multiple Myeloma.多发性骨髓瘤血栓并发症的当代风险评估、预防及管理方法
Cancers (Basel). 2022 Dec 16;14(24):6216. doi: 10.3390/cancers14246216.
3
A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis.

本文引用的文献

1
Mutational Epidemiology of Congenital Fibrinogen Disorders.先天性纤维蛋白原紊乱的突变流行病学。
Thromb Haemost. 2018 Nov;118(11):1867-1874. doi: 10.1055/s-0038-1673685. Epub 2018 Oct 17.
2
Natural history of patients with congenital dysfibrinogenemia.先天性纤维蛋白原异常血症患者的自然病史。
Blood. 2015 Jan 15;125(3):553-61. doi: 10.1182/blood-2014-06-582866. Epub 2014 Oct 15.
3
A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange.
多学科病例报告:多发性骨髓瘤伴肾和心脏受累——超越淀粉样变性的观察。
BMC Nephrol. 2022 Nov 17;23(1):370. doi: 10.1186/s12882-022-02984-4.
4
Integrated Analysis of m6A Methylome in Cisplatin-Induced Acute Kidney Injury and Berberine Alleviation in Mouse.顺铂诱导的小鼠急性肾损伤及小檗碱缓解作用中m6A甲基化组的综合分析
Front Genet. 2020 Nov 20;11:584460. doi: 10.3389/fgene.2020.584460. eCollection 2020.
Transfus Apher Sci. 2013 Feb;48(1):35-8. doi: 10.1016/j.transci.2012.06.021. Epub 2012 Jul 28.
4
Acquired dysfibrinogenemia secondary to multiple myeloma.继发于多发性骨髓瘤的获得性异常纤维蛋白原血症。
Acta Haematol. 2008;120(2):75-81. doi: 10.1159/000160182. Epub 2008 Oct 8.
5
Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain.由免疫球蛋白λ轻链单克隆产生引起的获得性异常纤维蛋白原血症。
Haematologica. 2007 Nov;92(11):e111-7. doi: 10.3324/haematol.11837.
6
An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient.
Haematologica. 2007 Feb;92(2):e17-9. doi: 10.3324/haematol.10575.
7
Coagulation defects in liver disease.肝脏疾病中的凝血缺陷。
Med Clin North Am. 1994 May;78(3):545-54. doi: 10.1016/s0025-7125(16)30146-8.
8
Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio.纤维蛋白原检测:六种不同方法的协作研究。意大利血液学和实验室方法标准化委员会(C.I.S.M.E.L.)
Clin Chem. 1991 May;37(5):714-9.
9
The roles of fibrinogen and fibrin in hemostasis and thrombosis.纤维蛋白原和纤维蛋白在止血和血栓形成中的作用。
Semin Hematol. 1992 Jul;29(3):177-88.